Phytochemicals Approach for Developing Cancer Immunotherapeutics

Phytochemicals or their derived compounds are being increasingly recognized as potentially potent complementary treatments for cancer. Among them, some phytochemicals are being actively evaluated for use as adjuvants in anticancer therapies. For instance, shikonin and hypericin were found to induce immunogenic cell death of specific cancer cells, and this effect was able to further activate the recognition activity of tumor cells by the host immune system. On the other hand, some derivatives of phytochemicals, such as dihydrobenzofuran lignan (Q2-3) have been found to induce the secretion of an endogenous anticancer factor, namely IL-25, from non-malignant cells. These findings suggest that phytochemicals or their derivatives confer a spectrum of different pharmacological activities, which contrasts with the current cytotoxic anticancer drugs commonly used in clinics. In this review, we have collected together pertinent information from recent studies about the biochemical and cellular mechanisms through which specific phytochemicals regulate target immune systems in defined tumor microenvironments. We have further highlighted the potential application of these immunotherapeutic modifiers in cell-based cancer vaccine systems. This knowledge provides useful technological support and know how for future applications of phytochemicals in cancer immunotherapy.

[1]  Chao-Yie Yang,et al.  Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges. , 2017, Cold Spring Harbor perspectives in medicine.

[2]  A. Schneeweiss,et al.  Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2) , 2017, Breast Cancer Research and Treatment.

[3]  G. Lai,et al.  Activation of p53/miR-34a Tumor Suppressor Axis by Chinese Herbal Formula JP-1 in A549 Lung Adenocarcinoma Cells , 2016, Evidence-based complementary and alternative medicine : eCAM.

[4]  L. Shyur,et al.  Phytomedicine-Modulating oxidative stress and the tumor microenvironment for cancer therapy. , 2016, Pharmacological research.

[5]  Thomas Efferth,et al.  The role of p53 in cancer drug resistance and targeted chemotherapy , 2016, Oncotarget.

[6]  Yet-Ran Chen,et al.  Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis , 2016, Scientific Reports.

[7]  L. Shyur,et al.  Phytomedicine polypharmacology: Cancer therapy through modulating the tumor microenvironment and oxylipin dynamics. , 2016, Pharmacology & therapeutics.

[8]  Lin He,et al.  Phytochemical regulation of the tumor suppressive microRNA, miR‐34a, by p53‐dependent and independent responses in human breast cancer cells , 2016, Molecular carcinogenesis.

[9]  Wen-Hwa Lee,et al.  Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis , 2016, Nature Communications.

[10]  S. Pedraza,et al.  Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin , 2016, Oncotarget.

[11]  Abhishek D. Garg,et al.  Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma , 2016, Science Translational Medicine.

[12]  Michael R. Speicher,et al.  The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis , 2016, Science Translational Medicine.

[13]  W. Liang,et al.  Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine , 2015, PloS one.

[14]  N. Yang,et al.  Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components , 2015, Molecular Cancer.

[15]  N. Yang,et al.  Specific Medicinal Plant Polysaccharides Effectively Enhance the Potency of a DC-Based Vaccine against Mouse Mammary Tumor Metastasis , 2015, PloS one.

[16]  T. Efferth,et al.  Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1 , 2014, Oncotarget.

[17]  K Botzenhart,et al.  Reactive Oxygen Species , 2014 .

[18]  J. Bajorath,et al.  Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.

[19]  Ning Li,et al.  Codonopsis pilosula Polysaccharide Attenuates Cecal Ligation and Puncture Sepsis via Circuiting Regulatory T Cells in Mice , 2014, Shock.

[20]  Jianwen Liu,et al.  Hypericin-based Photodynamic Therapy Induces a Tumor-Specific Immune Response and an Effective DC-based cancer Immunotherapy. , 2014, Biochemical pharmacology.

[21]  Ning Yang,et al.  Protection Against Lung Cancer Patient Plasma-Induced Lymphocyte Suppression by Ganoderma Lucidum Polysaccharides , 2014, Cellular Physiology and Biochemistry.

[22]  M. Khorramizadeh,et al.  Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer , 2014, Cancer medicine.

[23]  N. Yang,et al.  Therapeutic Applications of Herbal Medicines for Cancer Patients , 2013, Evidence-based complementary and alternative medicine : eCAM.

[24]  N. Yang,et al.  Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  N. Yang,et al.  The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing , 2013, Evidence-based complementary and alternative medicine : eCAM.

[26]  R. Agarwal,et al.  Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy. , 2013, Current cancer drug targets.

[27]  S. Singhal,et al.  Myeloid derived suppressor cells , 2013, Oncoimmunology.

[28]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[29]  P. Vandenabeele,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[30]  J. Vaz,et al.  Suillus collinitus methanolic extract increases p53 expression and causes cell cycle arrest and apoptosis in a breast cancer cell line. , 2012, Food chemistry.

[31]  Yi-Zhun Zhu,et al.  Cochinchina Momordica Seed Extract Induces Apoptosis and Cell Cycle Arrest in Human Gastric Cancer Cells Via PARP and p53 Signal Pathways , 2012, Nutrition and cancer.

[32]  F. Sheu,et al.  Investigating the function of a novel protein from Anoectochilus formosanus which induced macrophage differentiation through TLR4-mediated NF-κB activation. , 2012, International immunopharmacology.

[33]  Zhihua Liu,et al.  [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine]. , 2012, Yao xue xue bao = Acta pharmaceutica Sinica.

[34]  J. Lieberman,et al.  Alterations in RNA processing during immune-mediated programmed cell death , 2012, Proceedings of the National Academy of Sciences.

[35]  N. Yang,et al.  Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine , 2012, Cancer Immunology, Immunotherapy.

[36]  Jai-Sing Yang,et al.  Activations of Both Extrinsic and Intrinsic Pathways in HCT 116 Human Colorectal Cancer Cells Contribute to Apoptosis through p53-Mediated ATM/Fas Signaling by Emilia sonchifolia Extract, a Folklore Medicinal Plant , 2012, Evidence-based complementary and alternative medicine : eCAM.

[37]  M. Swartz,et al.  Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity , 2012, Nature Reviews Cancer.

[38]  W. Su,et al.  Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. , 2012, Journal of ethnopharmacology.

[39]  Shih-Hsiung Wu,et al.  Dioscorea Phytocompounds Enhance Murine Splenocyte Proliferation Ex Vivo and Improve Regeneration of Bone Marrow Cells In Vivo , 2011, Evidence-based complementary and alternative medicine : eCAM.

[40]  M. Bissell,et al.  IL-25 Causes Apoptosis of IL-25R–Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells , 2011, Science Translational Medicine.

[41]  S. Tilley,et al.  Therapeutic Applications , 2011, Sub-cellular biochemistry.

[42]  C. F. Bannwart,et al.  Inhibitory effect of silibinin on tumour necrosis factor-alpha and hydrogen peroxide production by human monocytes , 2010, Natural product research.

[43]  Yi-an Chen,et al.  Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling , 2010, BMC Genomics.

[44]  K. Wiman,et al.  Pharmacological reactivation of mutant p53: from protein structure to the cancer patient , 2010, Oncogene.

[45]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[46]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[47]  Shih-Hsiung Wu,et al.  Polysaccharides from Dioscorea batatas induce tumor necrosis factor-alpha secretion via Toll-like receptor 4-mediated protein kinase signaling pathways. , 2008, Journal of agricultural and food chemistry.

[48]  Shaomeng Wang,et al.  Targeting the MDM2-p53 Interaction for Cancer Therapy , 2008, Clinical Cancer Research.

[49]  J. Weinstein,et al.  Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters , 2008, Molecular Cancer Therapeutics.

[50]  N. Yang,et al.  Immunomodulatory effects of phytocompounds characterized by in vivo transgenic human GM-CSF promoter activity in skin tissues. , 2008, Journal of biomedical science.

[51]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[52]  N. Yang,et al.  A galactolipid possesses novel cancer chemopreventive effects by suppressing inflammatory mediators and mouse B16 melanoma. , 2007, Cancer research.

[53]  W. Cho,et al.  In vitro and in vivo anti-tumor effects of Astragalus membranaceus. , 2007, Cancer letters.

[54]  Genee Y. Lee,et al.  Targeting the tumor microenvironment. , 2007, Frontiers in bioscience : a journal and virtual library.

[55]  M. Sporn,et al.  The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.

[56]  B. Aggarwal,et al.  Anticancer potential of silymarin: from bench to bed side. , 2006, Anticancer research.

[57]  C. Bombardier,et al.  Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. , 2006, Journal of clinical epidemiology.

[58]  David Moher,et al.  Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement , 2006, Annals of Internal Medicine.

[59]  S. Fu,et al.  Dioscorin isolated from Dioscorea alata activates TLR4-signaling pathways and induces cytokine expression in macrophages. , 2006, Biochemical and biophysical research communications.

[60]  Hua Yu,et al.  Chinese herbal formula, Bing De Ling, enhances antitumor effects and ameliorates weight loss induced by 5-fluorouracil in the mouse CT26 tumor model. , 2005, DNA and cell biology.

[61]  Maxwell D Cummings,et al.  1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR. , 2005, Bioorganic & medicinal chemistry letters.

[62]  L. Vassilev,et al.  Targeting the p53–MDM2 interaction to treat cancer , 2004, British Journal of Cancer.

[63]  P. Tu,et al.  A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. , 2004, Biochemical and biophysical research communications.

[64]  M. You,et al.  Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models , 2004, Oncogene.

[65]  N. Yang,et al.  Shikonins, Phytocompounds from Lithospermum erythrorhizon, Inhibit the Transcriptional Activation of Human Tumor Necrosis Factor α Promoter in Vivo* , 2004, Journal of Biological Chemistry.

[66]  Galina Selivanova,et al.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.

[67]  M. Schubert-Zsilavecz,et al.  Comparison of German St. John's wort products according to hyperforin and total hypericin content. , 2001, Journal of the American Pharmaceutical Association.

[68]  S. Ansorge,et al.  Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin , 2001, Free radical research.

[69]  W. Isaacs,et al.  Genomic organization of the human KAI1 metastasis-suppressor gene. , 1997, Genomics.

[70]  Hun-taeg Chung,et al.  Reactive oxygen species in the activation of MAP kinases. , 2013, Methods in enzymology.

[71]  Liang Fang,et al.  [Application of network pharmacology and high through-put technology on active compounds screening from traditional Chinese medicine]. , 2012, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[72]  S. Nicosia,et al.  Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53. , 2010, Frontiers in bioscience.

[73]  Patrizia Agostinis,et al.  Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. , 2010, Biochimica et biophysica acta.

[74]  H. Harn,et al.  The extract of Hibiscus syriacus inducing apoptosis by activating p53 and AIF in human lung cancer cells. , 2008, The American journal of Chinese medicine.

[75]  Shaomeng Wang,et al.  Targeting theMDM 2p 53 Interaction for Cancer Therapy , 2008 .

[76]  S. Chiu,et al.  Inhibition of tumor necrosis factor-alpha through selective blockade of Pre-mRNA splicing by shikonin. , 2007, Molecular pharmacology.

[77]  S. Dooley,et al.  Isolation and characterization of the human genomic locus coding for the putative metastasis control gene nm23-H1 , 2004, Human Genetics.